DBV Technologies SA

DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq

05 Sep 2025 13:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

03 Sep 2025 13:30:00 By Nasdaq GlobeNewswire

Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025

01 Aug 2025 13:05:00 By Nasdaq GlobeNewswire

DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report

29 Jul 2025 13:17:35 By Nasdaq GlobeNewswire

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results

29 Jul 2025 13:08:23 By Nasdaq GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

28 Jul 2025 13:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer

22 Jul 2025 13:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old

25 Jun 2025 13:15:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming EAACI Congress 2025

12 Jun 2025 13:05:00 By Nasdaq GlobeNewswire

DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting

11 Jun 2025 13:30:00 By Nasdaq GlobeNewswire

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025

04 Jun 2025 13:32:09 By Nasdaq GlobeNewswire

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

03 Jun 2025 13:30:00 By Nasdaq GlobeNewswire

Combined General Meeting of June 11, 2025

15 May 2025 13:30:00 By Nasdaq GlobeNewswire

Information regarding the total number of voting rights and  total number of shares of the Company as of April 30, 2025

06 May 2025 13:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in the Citizens JMP Life Sciences Conference

05 May 2025 13:30:00 By Nasdaq GlobeNewswire

DBV Technologies Reports First Quarter 2025 Financial Results

30 Apr 2025 13:00:00 By Nasdaq GlobeNewswire

DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document

11 Apr 2025 13:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved

27 Mar 2025 19:30:05 By Nasdaq GlobeNewswire

DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...

23 Mar 2025 23:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress

25 Feb 2025 13:01:00 By Nasdaq GlobeNewswire